In a groundbreaking shift that's reshaping oncology in Asia, China's CAR T Cell Therapy Market is poised for explosive growth—emerging as a billion-dollar opportunity in the fight against cancer. Fueled by cutting-edge biotechnology, supportive government policies, and rising cancer prevalence, China is becoming a global epicenter for CAR T-cell innovation. CAR T-cell therapy, a...